Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207519 · ClinicalTrials.gov registry record · Phase 1
Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents
A Phase 1 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00207519 is a Phase 1 study that has completed, run by Boston Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT00207519, a Phase 1 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
In this 3-month pilot study, we will introduce to 40 adolescents "at risk for overweight" (i.e., a BMI/age \>85th percentile) a structured meal plan consisting of meal replacements, fruits, vegetables, whole grains, lean protein and dairy products. We will encourage and invite at least one parent to the scheduled visits, however, no subject will be eliminated because of lack of parental involvement. In this study, we will conduct behavior modification group sessions using lessons which are structured and patterned after the suggestions documented in the LEARNÒ Program for Weight Control. Diet instruction by a registered dietitian will include the appropriate use of meal replacements for a low-fat, low-calorie meal plan. Portion sizes of all foods recommended will be reviewed and a structured meal plan will be developed by the dietitian for subjects to follow. Subjects will return on a weekly basis for behavioral modification groups sessions in conjunction with the liquid meal replacement diet. Blood work and physical examinations will occur pre and post intervention.
Interventions
- BEHAVIORAL weekly behavioral modification group
- BEHAVIORAL liquid meal replacements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2003-04 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00207519
The ClinicalTrials.gov registry entry for NCT00207519 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which weekly behavioral modification group is the first listed.
NCT00207519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00207519 about?
NCT00207519 is a clinical study titled "Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents". In this 3-month pilot study, we will introduce to 40 adolescents "at risk for overweight" (i.e., a BMI/age \>85th percentile) a structured meal plan consisting of meal replacements, fruits, vegetables, whole grains, lean protein and dairy products. We will encourage and invite at least one parent to...
What is the current status of trial NCT00207519?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2003-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00207519?
The interventions under investigation include: weekly behavioral modification group (BEHAVIORAL), liquid meal replacements (BEHAVIORAL).
Who is sponsoring clinical trial NCT00207519?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.